| 0 |
INSTILLATION SITE DISCHARGE |
107 |
0.4068 |
| 1 |
FLUORESCENT IN SITU HYBRIDISATION POSITIVE |
1 |
0.1000 |
| 2 |
CYSTOSCOPY ABNORMAL |
3 |
0.0652 |
| 3 |
RADICAL CYSTECTOMY |
2 |
0.0571 |
| 4 |
EXPULSION OF MEDICATION |
25 |
0.0473 |
| 5 |
METASTASES TO TRACHEA |
1 |
0.0357 |
| 6 |
BLADDER SPASM |
62 |
0.0331 |
| 7 |
URINE CYTOLOGY ABNORMAL |
1 |
0.0303 |
| 8 |
CYTOLOGY ABNORMAL |
4 |
0.0267 |
| 9 |
URINARY CYSTECTOMY |
3 |
0.0254 |
| 10 |
CARCINOMA IN SITU |
3 |
0.0180 |
| 11 |
TRANSITIONAL CELL CARCINOMA RECURRENT |
1 |
0.0172 |
| 12 |
URINARY SEDIMENT |
1 |
0.0172 |
| 13 |
INSTILLATION SITE DISCOMFORT |
2 |
0.0149 |
| 14 |
BLADDER CANCER RECURRENT |
13 |
0.0130 |
| 15 |
BLADDER PAPILLOMA |
1 |
0.0128 |
| 16 |
CLINICALLY ISOLATED SYNDROME |
1 |
0.0105 |
| 17 |
PNEUMATURIA |
1 |
0.0104 |
| 18 |
COLD FLASH |
1 |
0.0086 |
| 19 |
SEPTIC ENCEPHALOPATHY |
1 |
0.0058 |
| 20 |
LOWER URINARY TRACT SYMPTOMS |
2 |
0.0055 |
| 21 |
PNEUMONIA ADENOVIRAL |
1 |
0.0051 |
| 22 |
NORMOCHROMIC ANAEMIA |
1 |
0.0050 |
| 23 |
BLADDER DISCOMFORT |
6 |
0.0048 |
| 24 |
SPINAL CORD HAEMATOMA |
1 |
0.0047 |
| 25 |
URINARY TRACT DISCOMFORT |
2 |
0.0043 |
| 26 |
BLADDER NEOPLASM |
7 |
0.0041 |
| 27 |
BLADDER IRRITATION |
2 |
0.0031 |
| 28 |
ANION GAP DECREASED |
1 |
0.0029 |
| 29 |
MICTURITION URGENCY |
29 |
0.0025 |
| 30 |
INSTILLATION SITE IRRITATION |
3 |
0.0025 |
| 31 |
CITROBACTER INFECTION |
1 |
0.0023 |
| 32 |
BLADDER OBSTRUCTION |
1 |
0.0019 |
| 33 |
SCROTAL PAIN |
1 |
0.0019 |
| 34 |
GENITAL DISCOMFORT |
1 |
0.0018 |
| 35 |
NEOPLASM RECURRENCE |
5 |
0.0015 |
| 36 |
CYTOKINE STORM |
1 |
0.0015 |
| 37 |
EXPOSURE VIA BODY FLUID |
1 |
0.0013 |
| 38 |
TONGUE PRURITUS |
1 |
0.0012 |
| 39 |
GENITAL BURNING SENSATION |
1 |
0.0012 |
| 40 |
URGE INCONTINENCE |
1 |
0.0011 |
| 41 |
URINARY TRACT INFECTION ENTEROCOCCAL |
1 |
0.0011 |
| 42 |
KLEBSIELLA BACTERAEMIA |
1 |
0.0011 |
| 43 |
DISEASE RECURRENCE |
48 |
0.0010 |
| 44 |
PRODUCT ADMINISTRATION INTERRUPTED |
7 |
0.0009 |
| 45 |
LABILE BLOOD PRESSURE |
1 |
0.0008 |
| 46 |
PHARYNGEAL HAEMORRHAGE |
1 |
0.0008 |
| 47 |
INCONTINENCE |
8 |
0.0008 |
| 48 |
CYSTITIS NONINFECTIVE |
1 |
0.0007 |
| 49 |
CALCULUS BLADDER |
1 |
0.0007 |
| 50 |
VIRAEMIA |
1 |
0.0007 |
| 51 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
0.0007 |
| 52 |
BLADDER TRANSITIONAL CELL CARCINOMA |
1 |
0.0007 |
| 53 |
ADENOVIRUS INFECTION |
2 |
0.0007 |
| 54 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
14 |
0.0006 |
| 55 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
0.0006 |
| 56 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 57 |
DYSURIA |
21 |
0.0006 |
| 58 |
HAEMATURIA |
19 |
0.0006 |
| 59 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 60 |
BLOOD URINE PRESENT |
9 |
0.0005 |
| 61 |
URINE OUTPUT DECREASED |
4 |
0.0005 |
| 62 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 63 |
URINE FLOW DECREASED |
1 |
0.0004 |
| 64 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 65 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 66 |
VULVOVAGINAL PRURITUS |
2 |
0.0004 |
| 67 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 68 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 69 |
FEELING OF BODY TEMPERATURE CHANGE |
2 |
0.0003 |
| 70 |
POLLAKIURIA |
14 |
0.0003 |
| 71 |
BLADDER PAIN |
1 |
0.0003 |
| 72 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0003 |
| 73 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 74 |
MICTURITION DISORDER |
1 |
0.0003 |
| 75 |
INFLUENZA LIKE ILLNESS |
22 |
0.0003 |
| 76 |
SPINAL CORD COMPRESSION |
1 |
0.0003 |
| 77 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 78 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 79 |
RECURRENT CANCER |
1 |
0.0002 |
| 80 |
URINARY INCONTINENCE |
7 |
0.0002 |
| 81 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 82 |
BONE CANCER |
1 |
0.0002 |
| 83 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 84 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 85 |
URINARY TRACT DISORDER |
1 |
0.0002 |
| 86 |
CHILLS |
26 |
0.0002 |
| 87 |
FLANK PAIN |
2 |
0.0002 |
| 88 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 89 |
BRAIN FOG |
3 |
0.0002 |
| 90 |
POLYARTHRITIS |
1 |
0.0002 |
| 91 |
VULVOVAGINAL BURNING SENSATION |
1 |
0.0002 |
| 92 |
METASTASIS |
1 |
0.0001 |
| 93 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 94 |
DISEASE PROGRESSION |
15 |
0.0001 |
| 95 |
CYSTITIS |
4 |
0.0001 |
| 96 |
POLYURIA |
1 |
0.0001 |
| 97 |
URINARY RETENTION |
4 |
0.0001 |
| 98 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 99 |
PYREXIA |
40 |
0.0001 |
| 100 |
DISCOMFORT |
7 |
0.0001 |
| 101 |
FACIAL PAIN |
1 |
0.0001 |
| 102 |
THERAPY NON-RESPONDER |
5 |
0.0001 |
| 103 |
LIP DRY |
1 |
0.0001 |
| 104 |
OPTIC NEURITIS |
1 |
0.0001 |
| 105 |
UROSEPSIS |
1 |
0.0001 |
| 106 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 107 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 108 |
HEPATOMEGALY |
1 |
0.0001 |
| 109 |
THERAPY CHANGE |
1 |
0.0001 |
| 110 |
BLADDER DISORDER |
1 |
0.0001 |
| 111 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 112 |
EAR DISCOMFORT |
1 |
0.0001 |
| 113 |
SUDDEN DEATH |
1 |
0.0001 |
| 114 |
RENAL PAIN |
1 |
0.0001 |
| 115 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 116 |
NEOPLASM |
1 |
0.0001 |
| 117 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 118 |
BURNING SENSATION |
6 |
0.0001 |
| 119 |
NOCTURIA |
1 |
0.0001 |
| 120 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 121 |
AGEUSIA |
2 |
0.0001 |
| 122 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 123 |
BEDRIDDEN |
1 |
0.0001 |
| 124 |
DISORIENTATION |
3 |
0.0001 |
| 125 |
ADVERSE REACTION |
1 |
0.0001 |
| 126 |
TREATMENT FAILURE |
6 |
0.0001 |
| 127 |
MASS |
1 |
0.0001 |
| 128 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 129 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
5 |
0.0001 |
| 130 |
ANOSMIA |
1 |
0.0001 |
| 131 |
LYMPHOMA |
1 |
0.0001 |
| 132 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 133 |
ANKLE FRACTURE |
1 |
0.0001 |
| 134 |
METASTASES TO BONE |
1 |
0.0001 |
| 135 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 136 |
GAIT INABILITY |
2 |
0.0001 |
| 137 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 138 |
PERICARDITIS |
1 |
0.0001 |
| 139 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 140 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 141 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 142 |
SYRINGE ISSUE |
1 |
0.0001 |
| 143 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 144 |
PANCYTOPENIA |
3 |
0.0001 |
| 145 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 146 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 147 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 148 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 149 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 150 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 151 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 152 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 153 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 154 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 155 |
FATIGUE |
35 |
0.0000 |
| 156 |
SEPSIS |
5 |
0.0000 |
| 157 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 158 |
INCORRECT DOSE ADMINISTERED |
10 |
0.0000 |
| 159 |
CARDIAC DISORDER |
4 |
0.0000 |
| 160 |
SLEEP DISORDER |
3 |
0.0000 |
| 161 |
PRESYNCOPE |
1 |
0.0000 |
| 162 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 163 |
DECREASED APPETITE |
9 |
0.0000 |
| 164 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 165 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 166 |
FEELING COLD |
1 |
0.0000 |
| 167 |
HYPONATRAEMIA |
2 |
0.0000 |
| 168 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 169 |
HYPERSOMNIA |
1 |
0.0000 |
| 170 |
LETHARGY |
2 |
0.0000 |
| 171 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
7 |
0.0000 |
| 172 |
DYSSTASIA |
1 |
0.0000 |
| 173 |
BLADDER CANCER |
2 |
0.0000 |
| 174 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 175 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 176 |
HOSPITALISATION |
5 |
0.0000 |
| 177 |
HEAD INJURY |
1 |
0.0000 |
| 178 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 179 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 180 |
RHINORRHOEA |
2 |
0.0000 |
| 181 |
PAIN |
19 |
0.0000 |
| 182 |
SYNCOPE |
3 |
0.0000 |
| 183 |
ASTHENIA |
11 |
0.0000 |
| 184 |
DEATH |
25 |
0.0000 |
| 185 |
WEIGHT DECREASED |
8 |
0.0000 |
| 186 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 187 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
| 188 |
MUSCLE SPASMS |
5 |
0.0000 |
| 189 |
DYSARTHRIA |
1 |
0.0000 |
| 190 |
HOT FLUSH |
2 |
0.0000 |
| 191 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 192 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 193 |
DYSKINESIA |
1 |
0.0000 |
| 194 |
TREMOR |
4 |
0.0000 |
| 195 |
HEADACHE |
15 |
0.0000 |
| 196 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 197 |
LIVER DISORDER |
1 |
0.0000 |
| 198 |
TACHYCARDIA |
2 |
0.0000 |
| 199 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 200 |
ADVERSE EVENT |
2 |
0.0000 |
| 201 |
VOMITING |
10 |
0.0000 |
| 202 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 203 |
HEART RATE INCREASED |
2 |
0.0000 |
| 204 |
DRUG INEFFECTIVE |
26 |
0.0000 |
| 205 |
FLUSHING |
2 |
0.0000 |
| 206 |
FLUID RETENTION |
1 |
0.0000 |
| 207 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 208 |
THERAPY CESSATION |
1 |
0.0000 |
| 209 |
ILLNESS |
2 |
0.0000 |
| 210 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 211 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 212 |
MYALGIA |
3 |
0.0000 |
| 213 |
DIARRHOEA |
11 |
0.0000 |
| 214 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 215 |
HYPERHIDROSIS |
2 |
0.0000 |
| 216 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 217 |
NAUSEA |
12 |
0.0000 |
| 218 |
DEHYDRATION |
2 |
0.0000 |
| 219 |
DRY SKIN |
2 |
0.0000 |
| 220 |
MOBILITY DECREASED |
1 |
0.0000 |
| 221 |
INFECTION |
2 |
0.0000 |
| 222 |
UNDERDOSE |
1 |
0.0000 |
| 223 |
DYSGEUSIA |
1 |
0.0000 |
| 224 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 225 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 226 |
ARTHRITIS |
1 |
0.0000 |
| 227 |
DRY MOUTH |
1 |
0.0000 |
| 228 |
CARDIAC ARREST |
1 |
0.0000 |
| 229 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 230 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 231 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 232 |
DIZZINESS |
5 |
0.0000 |
| 233 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 234 |
ERYTHEMA |
2 |
0.0000 |
| 235 |
MALAISE |
4 |
0.0000 |
| 236 |
FALL |
3 |
0.0000 |
| 237 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 238 |
SEIZURE |
1 |
0.0000 |
| 239 |
PALPITATIONS |
1 |
0.0000 |
| 240 |
FEELING ABNORMAL |
2 |
0.0000 |
| 241 |
JOINT SWELLING |
1 |
0.0000 |
| 242 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 243 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 244 |
VISION BLURRED |
1 |
0.0000 |
| 245 |
ARTHRALGIA |
3 |
0.0000 |
| 246 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 247 |
PNEUMONIA |
2 |
0.0000 |
| 248 |
URTICARIA |
1 |
0.0000 |
| 249 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 250 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 251 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 252 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 253 |
DYSPNOEA |
3 |
0.0000 |
| 254 |
ALOPECIA |
1 |
0.0000 |
| 255 |
HYPOTENSION |
1 |
0.0000 |
| 256 |
RASH |
2 |
0.0000 |
| 257 |
CONSTIPATION |
1 |
0.0000 |
| 258 |
BACK PAIN |
1 |
0.0000 |
| 259 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 260 |
INSOMNIA |
1 |
0.0000 |
| 261 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 262 |
PRURITUS |
1 |
0.0000 |
| 263 |
OFF LABEL USE |
2 |
0.0000 |